Altus accuses Lonza of breaching contract
Altus Pharmaceuticals has terminated its contract with Lonza over an alleged breach in the agreement to provide active pharmaceutical ingredients (API) for Trizytek (liprotamase).
Archives for June 30, 2009
Lantus cancer link research flawed says Sanofi; mulls R&D restructuring
Sanofi-Aventis has moved to defend its long-acting diabetes treatment Lantus (insulin glargine) and says that recent research linking it to the development of cancer is of “poor quality.”
Teva collaborates to save failed drugs
Teva plans to acquire oncology drugs that fail late-stage clinical trials and collaborate with Optimata to "efficiently rescue" the therapeutics and gain regulatory approval.
Rottapharm expanding Irish operations
Rottapharm is investing €7m ($9.8m) in its Irish manufacturing operations, which will create 35 jobs and add 2000 sq m housing three manufacturing and associated packaging lines.
TFS and Siemens hope to have process analysis down PAT
US group Thermo Fisher Scientific and industrial engineering giant Siemens have teamed up to offer the pharmaceutical industry a new way of assessing processes used during early drug development, manufacturing scale up and commercial production.
PSI collaborates with Microfluidics
Particle Sciences (PSI) is aiming to advance its contract processing offering by collaborating with Microfluidics and sharing formulation and nanotechnology expertise.
Phase Forward signs new deal with GSK
Data management specialist Phase Forward has landed a “multi-million dollar” clinical trial services contract with GSK.